Jump to Content
ADGC
Alzheimer's Disease
Genetics Consortium
Home
ADGC Core Projects
Contact
About
Program Overview
Members
Committees
Links
Alzheimer's Disease
Acknowledgements
Collaborative Data Access (SAGs)
SAG Proposal Instructions
SAG Overview
Current ADGC Special Analysis Group Projects (SAGs)
Publications
ADGC Publications
Publications Supported by the ADGC
Publications Using ADGC and IGAP Summary Statistics
For Members
Login
You are here
Home
» ADGC Publications
ADGC Publications
Found 5 results
Filters:
Keyword
is
Phosphorylation
[Clear All Filters]
2018
Ikezu T
,
Chen CD
,
DeLeo AM
,
Zeldich E
,
M Fallin D
,
Kanaan NM
,
Lunetta KL
,
Abraham CR
,
Logue MW
,
Farrer LA
. 2018.
Tau Phosphorylation is Impacted by Rare AKAP9 Mutations Associated with Alzheimer Disease in African Americans.
.
J Neuroimmune Pharmacol. 13(2):254-264.
2014
Jun G
,
Asai H
,
Zeldich E
,
Drapeau E
,
Chen CD
,
Chung J
,
Park J-H
,
Kim S
,
Haroutunian V
,
Foroud T
et al.
. 2014.
PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation.
.
Ann Neurol. 76(3):379-92.
Ramirez A
,
van der Flier WM
,
Herold C
,
Ramonet D
,
Heilmann S
,
Lewczuk P
,
Popp J
,
Lacour A
,
Drichel D
,
Louwersheimer E
et al.
. 2014.
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.
.
Hum Mol Genet. 23(24):6644-58.
2013
Cruchaga C
,
Kauwe JSK
,
Harari O
,
Jin SChih
,
Cai Y
,
Karch CM
,
Benitez BA
,
Jeng AT
,
Skorupa T
,
Carrell D
et al.
. 2013.
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
.
Neuron. 78(2):256-68.
2010
Melrose HL
,
Dächsel JC
,
Behrouz B
,
Lincoln SJ
,
Yue M
,
Hinkle KM
,
Kent CB
,
Korvatska E
,
Taylor JP
,
Witten L
et al.
. 2010.
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice.
.
Neurobiol Dis. 40(3):503-17.